Skip to main content
Top
Published in: Rheumatology International 10/2009

01-08-2009 | Original Article

Distribution of HLA-B27 and its alleles in patients with reactive arthritis and with ankylosing spondylitis in Tunisia

Authors: Mariam Siala, Nadia Mahfoudh, Radhouane Gdoura, Mohamed Younes, Hela Fourati, Arwa Kammoun, Ilhem Chour, Nihel Meddeb, Lilia Gaddour, Faiza Hakim, Sofien Baklouti, Naceur Bargaoui, Sleheddine Sellami, Adnene Hammami, Hafedh Makni

Published in: Rheumatology International | Issue 10/2009

Login to get access

Abstract

The purpose of the present study is to investigate the frequency of HLA-B27 and its alleles in reactive arthritis (ReA) and in ankylosing spondylitis (AS) in Tunisia. HLA-B27 alleles were typed by PCR amplification with sequence-specific primers. We studied 17 patients with ReA associated with urethritis or with gastrointestinal infection; 42 HLA-B27-positive patients with AS and 100 healthy controls. Eleven ReA patients (67.7%) were HLA-B27 positive. There was an increased frequencies of HLA-B27 (P = 7.76 × 10−12, OR = 59.30) and a moderate increase of HLA-B51 (P = 0.015; OR = 4.91) alleles in ReA patients when compared with healthy controls. Four B27 subtypes were identified: B*2702, 05, 09 and B*2712. The distribution of these alleles in the ReA patients was 37.5% for B*2702 and B*2705. Only these two subtypes were detected in 18 (42.8%) and 24 (57.1%), respectively, of the AS patients. B*2709 and B*2712 were relatively rare in ReA patients and were identified in one case each. Our results showed a restricted number of HLA-B27 subtypes associated with ReA and AS. B*2702 and 2705 were common in ReA and AS patients.
Literature
4.
go back to reference Vähämiko S, Penttinen MA, Granfors K (2005) Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27. Arthritis Res Ther 7:136–141. doi:10.1186/ar1762 PubMedCrossRef Vähämiko S, Penttinen MA, Granfors K (2005) Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27. Arthritis Res Ther 7:136–141. doi:10.​1186/​ar1762 PubMedCrossRef
6.
go back to reference Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704–706PubMed Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704–706PubMed
7.
go back to reference Erbinger A (1992) Ankylosing spondylitis is caused by Klebsiella. Rheum Dis Clin North Am 18:105–121 Erbinger A (1992) Ankylosing spondylitis is caused by Klebsiella. Rheum Dis Clin North Am 18:105–121
8.
go back to reference Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki LM, Suoranta H, Nissilä M, Hvidman L, Nielsen ED, Svejgaard A, Tilikainen A, Laitinen O (1982) Followup study on patients with Reiter’s disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 25:249–259. doi:10.1002/art.1780250302 PubMedCrossRef Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki LM, Suoranta H, Nissilä M, Hvidman L, Nielsen ED, Svejgaard A, Tilikainen A, Laitinen O (1982) Followup study on patients with Reiter’s disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 25:249–259. doi:10.​1002/​art.​1780250302 PubMedCrossRef
9.
go back to reference Good AE (1965) Reiter’s disease and ankylosing spondylitis. Acta Rheumatol Scand 11:305–317PubMed Good AE (1965) Reiter’s disease and ankylosing spondylitis. Acta Rheumatol Scand 11:305–317PubMed
10.
go back to reference Sairanen E, Paronen I, Mähönen H (1969) Reiter’s syndrome: a follow-up study. Acta Med Scand 185:57–63PubMed Sairanen E, Paronen I, Mähönen H (1969) Reiter’s syndrome: a follow-up study. Acta Med Scand 185:57–63PubMed
11.
go back to reference Arnett FC, Hochberg MC, Bias WB (1977) Cross-reactive HLA antigens in B27-negative Reiter’s syndrome and sacroiliitis. Johns Hopkins Med J 141:193–197PubMed Arnett FC, Hochberg MC, Bias WB (1977) Cross-reactive HLA antigens in B27-negative Reiter’s syndrome and sacroiliitis. Johns Hopkins Med J 141:193–197PubMed
12.
go back to reference Ben-Chetrit E, Brautbar C, Rubinow A (1985) HLA antigens in Reiter’s syndrome in Israeli patients. J Rheumatol 12:964–966PubMed Ben-Chetrit E, Brautbar C, Rubinow A (1985) HLA antigens in Reiter’s syndrome in Israeli patients. J Rheumatol 12:964–966PubMed
13.
go back to reference Stein M, Davis P, Emmanuel J, West G (1990) The spondyloarthropathies in Zimbabwe: a clinical and immunologic profile. J Rheumatol 17:1337–1339PubMed Stein M, Davis P, Emmanuel J, West G (1990) The spondyloarthropathies in Zimbabwe: a clinical and immunologic profile. J Rheumatol 17:1337–1339PubMed
14.
17.
go back to reference Cuttica RJ, Scheines EJ, Garay SM, Romanelli MDC, Maldonado-Cocco JA (1992) Juvenile onset Reiter’s syndrome. A retrospective study of 26 patients. Clin Exp Rheumatol 10:285–288PubMed Cuttica RJ, Scheines EJ, Garay SM, Romanelli MDC, Maldonado-Cocco JA (1992) Juvenile onset Reiter’s syndrome. A retrospective study of 26 patients. Clin Exp Rheumatol 10:285–288PubMed
18.
go back to reference Vargas-Alarcón G, Londoño JD, Hernández-Pacheco G et al (2002) Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 61:714–717. doi:10.1136/ard.61.8.714 PubMedCrossRef Vargas-Alarcón G, Londoño JD, Hernández-Pacheco G et al (2002) Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 61:714–717. doi:10.​1136/​ard.​61.​8.​714 PubMedCrossRef
19.
go back to reference Sampaio-Barros PD, Conde RA, Donadi EA et al (2003) Undifferentiated spondyloarthropathies in Brazilians: importance of HLAB27 and the B7-CREG alleles in characterization and disease progression. J Rheumatol 30:2632–2637PubMed Sampaio-Barros PD, Conde RA, Donadi EA et al (2003) Undifferentiated spondyloarthropathies in Brazilians: importance of HLAB27 and the B7-CREG alleles in characterization and disease progression. J Rheumatol 30:2632–2637PubMed
20.
go back to reference Sampaio-Barros PD, Bertolo MB, Kraemer MHS, Marques Neto JF, Samara AM (2001) Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol 28:560–565PubMed Sampaio-Barros PD, Bertolo MB, Kraemer MHS, Marques Neto JF, Samara AM (2001) Primary ankylosing spondylitis: patterns of disease in a Brazilian population of 147 patients. J Rheumatol 28:560–565PubMed
22.
go back to reference Gonzalez-Roces S, Alvarez MW, Gonzalez S et al (1997) HLA B27 polymorphism and world-wide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123PubMedCrossRef Gonzalez-Roces S, Alvarez MW, Gonzalez S et al (1997) HLA B27 polymorphism and world-wide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123PubMedCrossRef
23.
go back to reference Brown MA, Jepson A, Young A et al (1997) Ankylosing spondylitis in West Africans evidence for a non HLA B27 protective effect. Ann Rheum Dis 56:68–70PubMedCrossRef Brown MA, Jepson A, Young A et al (1997) Ankylosing spondylitis in West Africans evidence for a non HLA B27 protective effect. Ann Rheum Dis 56:68–70PubMedCrossRef
26.
go back to reference Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D et al (2004) HLA B27 in the Greek Cypriot population distribution of subtypes in patients with ankylosing spondylitis and other HLA B27 related diseases. The possible protective rôle of B*2707. Hum Immunol 65:1451–1454. doi:10.1016/j.humimm.2004.08.177 PubMedCrossRef Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D et al (2004) HLA B27 in the Greek Cypriot population distribution of subtypes in patients with ankylosing spondylitis and other HLA B27 related diseases. The possible protective rôle of B*2707. Hum Immunol 65:1451–1454. doi:10.​1016/​j.​humimm.​2004.​08.​177 PubMedCrossRef
27.
go back to reference Scordaki Z, Spyropoulou-Vlachou M, Vrani V, et al. (2003) Polymorphism of HLA-B27 alleles in association with HLA-B27 related diseases in Greek population. Hum Immunol 1:S144#195 Scordaki Z, Spyropoulou-Vlachou M, Vrani V, et al. (2003) Polymorphism of HLA-B27 alleles in association with HLA-B27 related diseases in Greek population. Hum Immunol 1:S144#195
28.
go back to reference Khan MA (1997) Prevalence of HLA B27 in world populations. In: Lopez-Larrea C (ed) HLA B27 in the development of spondyloarthropathies. Landes Spinger, Austin, pp 1–16 Khan MA (1997) Prevalence of HLA B27 in world populations. In: Lopez-Larrea C (ed) HLA B27 in the development of spondyloarthropathies. Landes Spinger, Austin, pp 1–16
29.
go back to reference Tamouza R, Awada H, Marzais F (1997) HLA B27 in the Lebanese population: subtypes analysis and association with ankylosing spondylitis. In: Charron D et al (eds) Genetic diversity of HLA: functional and medical implications. EDK, Paris, p 649 Tamouza R, Awada H, Marzais F (1997) HLA B27 in the Lebanese population: subtypes analysis and association with ankylosing spondylitis. In: Charron D et al (eds) Genetic diversity of HLA: functional and medical implications. EDK, Paris, p 649
31.
go back to reference Oguz FS, Ocal L, Diler AS et al (2004) HLAB27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20:309–312PubMed Oguz FS, Ocal L, Diler AS et al (2004) HLAB27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20:309–312PubMed
33.
go back to reference Fernandez-Sueiro JL, Alonso C, Blanco FJ et al (2004) Prevalence of HLA B27 and subtypes of HLAB27 associated with ankylosing spondylitis in Galicia, Spain. Clin Exp Rheumatol 122:465–468 Fernandez-Sueiro JL, Alonso C, Blanco FJ et al (2004) Prevalence of HLA B27 and subtypes of HLAB27 associated with ankylosing spondylitis in Galicia, Spain. Clin Exp Rheumatol 122:465–468
34.
go back to reference Grublic Z, Kerhin-Brkljacic V, Peric P et al (2001) Variation in HLA B27 gene subtypes and susceptibility of ankylosing spondylitis in the Croatian population. Reumatizam 48:7–11 Grublic Z, Kerhin-Brkljacic V, Peric P et al (2001) Variation in HLA B27 gene subtypes and susceptibility of ankylosing spondylitis in the Croatian population. Reumatizam 48:7–11
35.
go back to reference Fraile A, Martin J, Lopez-Nevot MA et al (1998) HLA B27 subtyping by PCR RFLP in Spanish patients with ankylosing spondylitis. Tissue Antigens 52:492–496PubMedCrossRef Fraile A, Martin J, Lopez-Nevot MA et al (1998) HLA B27 subtyping by PCR RFLP in Spanish patients with ankylosing spondylitis. Tissue Antigens 52:492–496PubMedCrossRef
36.
go back to reference Sampaio-Barros PD, Conde RA, Donadi EA, Bonfiglioli R, Costallat LT, Samara AM et al (2008) Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population. Rheumatol Int 28:483–486. doi:10.1007/s00296-007-0441-3 PubMedCrossRef Sampaio-Barros PD, Conde RA, Donadi EA, Bonfiglioli R, Costallat LT, Samara AM et al (2008) Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population. Rheumatol Int 28:483–486. doi:10.​1007/​s00296-007-0441-3 PubMedCrossRef
38.
Metadata
Title
Distribution of HLA-B27 and its alleles in patients with reactive arthritis and with ankylosing spondylitis in Tunisia
Authors
Mariam Siala
Nadia Mahfoudh
Radhouane Gdoura
Mohamed Younes
Hela Fourati
Arwa Kammoun
Ilhem Chour
Nihel Meddeb
Lilia Gaddour
Faiza Hakim
Sofien Baklouti
Naceur Bargaoui
Sleheddine Sellami
Adnene Hammami
Hafedh Makni
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0840-8

Other articles of this Issue 10/2009

Rheumatology International 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.